Ithaka Life Sciences' client ProteinLogic wins Med Tech award
Ithaka is pleased to announce that ProteinLogic, the biomarker discovery and exploitation company, was judged to have presented the strongest proposal in the Med Tech category to the Innovators’ Den at the NHS Healthcare Innovation Expo 2013 in London. Ithaka’s founder and Managing Director, Dr Paul Rodgers, is Executive Chairman of ProteinLogic.
Dr Rodgers presented the winning pitch to a panel including leading venture capitalists and senior NHS decision makers in front of a live audience. He outlined the ProteinLogic technology and its progress in implementing a business strategy to commercialise biomarker-based diagnostic tests for a range of diseases including tuberculosis and hepatitis B.
Eighty companies entered the competition and five were selected to present at the Innovators’ Den in each of three categories: Digital Innovations, Med Tech and Service Challenges. The competition was organised by the Technology Strategy Board and Capita.
Dr Rodgers said: “We are delighted with the recognition of ProteinLogic’s innovative technology and its business proposition provided by the distinguished panel of investors and NHS decision makers. We thank the Technology Strategy Board for giving us the opportunity to participate in the Innovators’ Den.”
Contact: Dr Paul Rodgers, telephone: +44 (0)1223 703146 email@example.com
Ithaka Life Sciences (Ithaka) provides expert advice, guidance, and hands-on support for organisations in the life sciences sector.